All episodes
The Bioengineered Hangover Cure: Changing the Conversation around GMOs with Zack Abbott of ZBiotics
Lance Baldo of Freenome on their Approach to Early Cancer Detection
Mara Aspinall on COVID
Terry Lo of Vizgen on Spatial Genomics
Proteomics at Scale Empowers Genomics in New Ways: Dale Yuzuki, Olink
A New Tool in the Genomics Kit with Ivan Liachko of Phase Genomics
Paul Kruszka of GeneDx/Sema4 on Groundbreaking Newborn Sequencing Study
Is PGx Having a Moment? Kristine Ashcraft, Invitae
Christian Henry on Revio, Onso and the New Vision at PacBio
The Revolution in Single Molecule Sequencing Continues: Vijay Ramani, UCSF
Will Hwang of Mass General on Discovery of Novel Pancreatic Cancer Cell Subtype
Going Beyond Time Barriers: Arutha Kulasinghe on the Power of New Spatial Biology Tools
Invitae’s Data Manager, Farid Vij, on New Genome Management Platform
Satellite Bio out with a New Tissue Based Approach to Regenerative Medicine
We Have to Get Sequencing Back to Moore’s Law: Gilad Almogy, Ultima Genomics
RNA Therapeutics: A New Paradigm for Drug Development? Tim Mercer, BASE Lab, U of Queensland
The System is Working. We Need More Engagement, Says ClinVar Champion Heidi Rehm of Mass General in Her Update on the State of Genomic Medicine in 2022
The Promise of Exosomes Now Realized, Says Paul Billings, CEO, Biological Dynamics
Lee Cronin on Origin of Life, Genomics, Aliens and More
Eric Green on the Future of the NHGRI
5-Base Sequencing: Jonas Korlach and Tomi Pastinen
More Cancer Patients Die from Infections than Cancer, Says Alec Ford, CEO of Karius
Some of the Lowest Hanging Fruits in Precision Medicine: Michelle Whirl-Carrillo on Pharmacogenomics
John Nelson of GE Research Talks Vaccines on Demand, Enzymatic Synthesis, and the Era of Writing DNA
A New Generation Comfortable Doing a Thousand Things at a Time Is Reinventing Life Science Says Joe Beechem of NanoString
Enabling a New Age of Unbiased Proteomics Discovery: Omid Farokhzad, Seer Inc.
The Rise of MRD Testing and the Field of Fragmentomics with Sugganth Daniel, Invitae
The Invention of Enzymatic DNA Synthesis with Sylvain Gariel, DNA Script
Akoya Biosciences Launches New Integrated Spatial Platform: Our First Interview with CEO Brian McKelligon
Harlan Robins on How T-cell Focused COVID Vaccines Can Move Us Toward Endemicity
Twist Bioscience: A New Kind of DNA Synthesis Company
Going High Resolution with 10X Genomics: Michael Schnall-Levin
George Church and Ben Lamm on the Launch of Colossal Biosciences
We Might Be the Comeback Kids of the Universe: Chris Mason on His Plan for the Next 500 Years
Invitae and PacBio CEOs Share Details of Clinical Sequencing Partnership
Building on the Knowledge Base of Developer Community, LuminexPLORE Lab Offers Custom Insights: Jackie Surls, Director
DNA Script Takes DNA Synthesis Back to the Bench with Enzymatic Tech: Thomas Ybert, CEO
Tumor Evolution in Context with Christina Curtis
The History of mRNA Vaccines with Elie Dolgin
Hundreds of Thousands of Biological Molecules Undiscovered in Plant Chemical Space Says Founder of New Drug Discovery Company
Quantitative Pathology with David Rimm, Yale
The State of Comprehensive Genomic Profiling at One of America’s Largest Health Systems with Carlo Bifulco
Inside the World of Genome Engineering at Amyris with Kirsten Benjamin, VP of R&D
Clinical Genetics 2021 Highlights: Laura Hercher, Host of the Beagle Landed Podcast
A New Way to Phenotype Life: Chris Mason Talks Spatial Biology, His New Book
The Impact of Spatial Technology on Childhood Cancers with David Steffin, Texas Children's
Robert Green: Newborn Sequencing Is the Goal Here in the U.S.
The Studies Are In—Optical Mapping Can Replace Traditional Cytogenetics Tests
Amy Sturm of Geisinger on FH Testing and New Implementation Science
Out of the Reductionist Trap: Brad Gray of NanoString on Spatial Biology
Precision Oncology at the Community Level with Lee Schwartzberg
Daniel Kraft on the Digitome and COVID
Orchid Health Is 1st in the World to Offer Whole Genome Couple's Report
PacBio and Labcorp Team Up on a Global Pan-Pathogen Surveillance Network
Will High Sensitivity Proteomics Enable a New Paradigm in Precision Health? with Kevin Hrusovsky, Quanterix
A Liquid Biopsy Technology that Doesn't Degrade the Sample: Raj Krishnan of Biological Dynamics
The Future of Big Biology: Bionano at AGBT
Playing Catch Up--Viral Surveillance in the U.S. with Will Lee of Helix
The Coronavirus, A Year On with Carl Zimmer
Spatial Biology Enables The Cancer Immunome Project
The CRISPR Saga with Kevin Davies
PacBio’s Never Been Stronger: New CEO, Christian Henry, Shares His Vision
Keith Robison on the State of Sequencing: 2020 Edition
Halloween with Nathan and Laura: The Spooky and Creepy of Genomics
When and Why Whole Genome Sequencing Should Be Standard of Care: Stephen Kingsmore of Rady Children’s
Limited Genetic Diversity Affects Us All
Genomics England Making Significant Strides in System Built on Trust in NHS
September 2020 Review with Nathan and Laura: Vaccine Choice, Dwarfism, Research Volunteerism
Bob Nussbaum on the State of Genetic Testing: 2020 Edition
SynBioBeta 2020 with John Cumbers
Mapping Intracellular Context: Garry Nolan on Spatial Biology
August 2020 Review: Radical Shift on LDT Policy, First Pan-Cancer Liquid Biopsies, and New Alzheimer’s Test
Using CRISPR Genome Editing Tools, Willow Biosciences out with First Synthetic Cannabinoid
The Pros and Cons of Expanded Carrier Screening with Mary Norton, UCSF
Is This A Unique Time for Science? We Ask Sci-fi Writer Kim Stanley Robinson
May 2020 with Nathan and Laura: Vaccine News, Notre Dame Argument, COVID Genetic Targets
Matt Loose on "Read Until" or Adaptive Sequencing
The Current State of Coronavirus Vaccines with Jeff Stein, Cidara Therapeutics
April 2020 Review with Nathan and Laura: Ioannidis Scandal, Antibody Testing, Ethics Questions
Lab Director Speaks to the Challenges of COVID-19 Testing: Elaine Lyon, HudsonAlpha
FDA in the Time of Coronavirus: Understanding the New VALID Act with Turna Ray, GenomeWeb
March 2020 Review with Nathan & Laura: Corona Gets Personal, Where Are the Tests?, the VALID Act, Some non-Corona Science
90% Go Undiagnosed, Says Geisinger’s Amy Sturm of FH Patients
Lisa Alderson on Her Telegenetics Firm, Genome Medical, Also Speaks to the DTC Downturn
February 2020 Review with Nathan and Laura: Coronavirus, Medicare for All, and Live from AGBT
Pouria Sanae on the DTC Slowdown and His New Precision Health Testing Platform
January 2020 Review: Genetic Counselors vs ACMG, 23andMe Layoffs, Privacy
End-of-Decade Review, What's Next? with Nathan and Laura
Ewan Birney on Race, UK Genomics
November 2019 with Nathan and Laura: Happy Birthday CRISPR Babies, 23andMe for Embryo Selection, and Golden Rice, Almost
Learning from the Field's Mistakes, Ancestry.com Rolls out Physician Ordered Health Testing
The Gene Edited Babies Saga - A Year Later with Hank Greely
Improving Quantitative Evidence for Genetic Tests: Carlos Araya, Invitae
The Meteoric Rise of Twist Bioscience and the Wild Demand for DNA: Emily Leproust, CEO
October 2019 Review with Nathan and Laura: Prime Editing, Vertex Win, and ASHG
Should We Increase Panel Testing for All Breast Cancer Patients?
Genomics Going from a Passive to an Active Science: John Stuelpnagel on the “Write” Revolution
Why Isn’t Personalized Medicine Being Mentioned by the Presidential Contenders? Ed Abrahams on Drug Pricing, Genetic Testing, and the State of the Industry in 2019
Karen Miga on the Next Era of Genomics
September 2019 Review with Nathan and Laura: Same-Sex Genetics, Mosquitos, and Another DTC Scandal